Nexalin Acquires Digital Health Platform to Support AI-Driven Neurostimulation Expansion
PushButton AI Team ·
Nexalin Acquires Digital Health Platform to Support AI-Driven Neurostimulation Expansion
Big healthcare companies aren't buying AI tools. They're buying AI that connects to their existing workflows.
That's the quiet lesson most business owners miss.
When you bought that AI tool nobody u
Big healthcare companies aren't buying AI tools. They're buying AI that connects to their existing workflows.
That's the quiet lesson most business owners miss.
When you bought that AI tool nobody uses, it wasn't your fault. The vendor sold you a solution looking for a problem. The consultant collected the check and vanished. That $200/month sitting idle isn't a technology failure — it's a fit failure.
Here's what the Nexalin acquisition reveals about smart AI adoption: the winning move isn't the flashiest tool. It's finding AI that plugs into what you already do — your patient records, your scheduling, your client data. Not a replacement. An extension.
The same principle works for your business. Before you evaluate any AI tool, write down the one manual task that eats the most hours each week. Just one. Then ask whether AI can reduce that specific task. That's your starting criteria — not features, not demos, not what your competitor is rumored to be using.
One problem. One solution. Measurable in 30 days.
That's how you get your first real win without blowing your budget or disrupting what already works.
What's the one repetitive task in your business you'd automate first if you knew it would actually work?
Nexalin said the acquired platform includes AI-integrated remote patient monitoring, electronic health record functionality, virtual clinic management ...
